CN Bio, a number one Organ-on-a-Chip (OOC) firm that designs and manufactures single- and multi-organ microphysiological techniques (MPS), at this time introduced the appointment of Joseph Parisi as US Director of Gross sales. In his new position, Joe will lead the growth of the Firm’s gross sales and help actions for the US market to deal with the rising demand for brand new various methodologies (NAMs) in preclinical drug discovery.
Following a number of key senior appointments within the UK final 12 months, Joe’s appointment will strengthen CN Bio’s progress in one other of its key markets – the US, offering an area supply of experience and help for patrons seeking to harness the Firm’s PhysioMimix® OOC vary of MPS. Over the previous 12 months, the worldwide demand for NAMs has accelerated, notably within the US following the enactment of the FDA Modernization Act 2.01. Joe’s gross sales experience might be essential for assembly this rising demand; working alongside the management workforce to drive the business growth technique, while supporting prospects to enhance the human relevance of preclinical workflows and cut back animal mannequin reliance.
Joe holds a robust monitor report in delivering profitable gross sales methods throughout the biotechnology sector. He joins CN Bio from Phenomix (acquired by Bruker Company in 2023), the place he was Director of Gross sales for US West and led an skilled gross sales workforce answerable for rising the proteomics facet of the enterprise. At Purigen Biosystems (acquired by Bionano Genomics in 2022), Joe was Director of West Coast Gross sales, the place he oversaw business growth, supporting the Firm’s progress from start-up to business success over three years. As a part of this, he led the event of inside business processes in addition to a pre-launch gross sales plan, serving to to speed up early gross sales and adoption. Moreover, he has held senior roles at quite a few life sciences organizations, together with Isoplexis, NanoString Applied sciences, and Life Applied sciences. Joe has a BSc in Molecular and Mobile Biology from the College of Illinois Urbana-Champaign.
The potential supplied by CN Bio’s PhysioMimix vary, substantiated by the Firm’s collaborative work with the FDA, is actually transformative for the drug discovery business, offering medical translatability that may enhance effectivity and decrease drug failures. In my new position, I stay up for harnessing my expertise inside the sector to help the design and implementation of a business technique that can allow us to satisfy the numerous demand for animal mannequin options right here within the US.”
Joe Parisi, US Director of Gross sales, CN Bio
Dr. Paul Brooks, Chief Govt Officer, mentioned: “It’s nice to welcome Joe to the workforce. All through his profession, he has repeatedly demonstrated his experience in biotech gross sales, with a confirmed historical past of success throughout firms in any respect phases of progress and commercialization. Joe’s appointment represents an essential milestone in CN Bio’s progress, having efficiently constructed a robust worldwide presence and now seeking to broaden this additional into the US, a key marketplace for modern drug discovery.”
